Eli Lilly (NYSE: LLY) stock was the picture of health on Friday. Shares of the massive American pharmaceutical company rose ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

New York, New York-- (Newsfile Corp. - February 5, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and ...

New York, New York-- (Newsfile Corp. - February 3, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and ...

Eli Lilly and venture capital firm Andreessen Horowitz ... Unveiled last year, Catalyze360 leverages Lilly Ventures, Lilly Gateway Labs and Lilly ExploR&D to create a multi-armed resource for ...

An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

Healthcare professionals will perform a health evaluation and any required lab work before discussing medication options. In August 2024, Eli Lilly announced that Zepbound would be available on ...

Eli Lilly has said it is prepared to invest £279 ... creation of a UK biotech hub – provisionally called Lilly Gateway Labs (LGL) – to support early-stage life sciences businesses working ...